Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Wolffs (Cardiff, United Kingdom), B. Mansfield (Cardiff, United Kingdom), R. Bruce (Cardiff, United Kingdom), L. Verckist (Antwerp, Belgium), R. Paes De Araújo (Ceredigion, United Kingdom), R. Attanoos (Cardiff, United Kingdom), D. Adriaensen (Antwerp, Belgium), L. Mur (Ceredigion, United Kingdom), B. Hope-Gill (Penarth, United Kingdom), D. Riccardi (Cardiff, United Kingdom). Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients. 1316

Member's Comments

No comment yet.

Related content which might interest you: Genes of glucocorticoid receptor and glutathione-S-transferase in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 333s Year: 2005 Late Breaking Abstract - Elevated growth differentiation factor 15 in serum correlated with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - A GATA3-specific DNAzyme attenuates sputum eosinophilia in COPD patients with eosinophilic airway inflammation Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - PK/PD assessment of an oral, selective aVß6/aVß1 integrin dual antagonist, PLN-74809, for the treatment of idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients Source: International Congress 2016 – IPF pathogenesis Year: 2016 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Plasma protein signature of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Is toll like receptor 4 a common pathway hypothesis for development of lung cancer and idiopathic pulmonary fibrosis? Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Dysregulation of the TGF-beta system in idiopathic pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 10s Year: 2004 Role of the inflammasome in idiopathic pulmonary fibrosis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Treatment of Idiopathic pulmonary fibrosis with interferon beta - our experience in seven patients Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 LSC Abstract – Enhanced expression of alarmins in pulmonary hypertension and fibrosis Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung Year: 2016 Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 LSC 2010 Abstract: Defective toll-like receptor-3 (TLR3) function promotes persistent interstitial lung disease and fibrosis in sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms Year: 2010 Blocking endothelin: breaking new ground Source: Eur Respir Rev 2008; 17: 24-29 Year: 2007 Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Expression of TGF-β1 and TGFβ receptors in lung tissue of patients with idiopathic interstitial pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016